Johnson & Johnson (JNJ) Share-based Compensation (2009 - 2026)
Johnson & Johnson (JNJ) recorded Share-based Compensation of $357 million in Q3 2026, up 2.9% from $347 million a year earlier but down 22.1% from the prior quarter.
Johnson & Johnson (JNJ) Share-based Compensation (2009 - 2026) Analysis & Trends
On a TTM basis, Johnson & Johnson's Share-based Compensation came in at $1.42 billion as of Sep 27, 2026, up 11.0% year-over-year; for FY2025, it was $1.35 billion, up 15.1% from FY2024.
- Annual Share-based Compensation has increased for three straight years, with a four-year compound annual growth rate of 7.7% (FY2021 to FY2025).
- Across earlier years, Share-based Compensation came in at $1.18 billion in FY2024 (+1.2%), $1.16 billion in FY2023 (+2.1%), $1.14 billion in FY2022 and $1.01 billion in FY2021.
- Quarterly Share-based Compensation has ranged from $178 million in Q4 2023 to $458 million in Q2 2026 over the past five years.
- On a year-over-year basis, Share-based Compensation has increased for six consecutive quarters, with growth averaging 14.4% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 33.7% in Q4 2024, against a decline of 18.3% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $458 million (Q2 2026), $300 million (Q1 2026) and $309 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Vertex Pharmaceuticals | 135.58 Bn | 107.59 Bn | 2.84 Bn | 170.20 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 357.00 Mn |
| Jun 28, 2026 | 458.00 Mn |
| Mar 29, 2026 | 300.00 Mn |
| Dec 28, 2025 | 309.00 Mn |
| Sep 28, 2025 | 347.00 Mn |
| Jun 29, 2025 | 410.00 Mn |
| Mar 30, 2025 | 288.00 Mn |
| Dec 29, 2024 | 238.00 Mn |
| Sep 29, 2024 | 295.00 Mn |
| Jun 30, 2024 | 341.00 Mn |
| Mar 31, 2024 | 302.00 Mn |
| Dec 31, 2023 | 178.00 Mn |
| Oct 1, 2023 | 296.00 Mn |
| Jul 2, 2023 | 382.00 Mn |
| Apr 2, 2023 | 306.00 Mn |
| Jan 1, 2023 | 218.00 Mn |
| Apr 3, 2022 | 278.00 Mn |
| Oct 3, 2021 | 259.00 Mn |
| Jul 4, 2021 | 354.00 Mn |
| Apr 4, 2021 | 307.00 Mn |
Johnson & Johnson Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=JNJ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();